Moreover, mutations in ASXL1 and TET2, a frequent finding in aCML, correlate with older age and monocytosis (TET2), are related to “clonal hematopoiesis of indeterminate potential” (CHIP), and are present in the founder clones of both MDS and MPN. This evidence concerns the gene TET2 and myelodysplastic syndrome.